| http://dbpedia.org/ontology/abstract
|
Arven Pharmaceuticals is a Turkish pharmac … Arven Pharmaceuticals is a Turkish pharmaceutical corporation headquartered in Istanbul established as a subsidiary of Toksöz Group in 2013. Arven’s primary focus is development and production of high-technology inhaler and biotechnology products. The company is specialized on difficult to make products. Arven is the first Turkish company developing biosimilars for global markets, including the US and EU. Arven has obtained a marketing authorization in 2016 for the biosimilar of Filgrastim, marketed under Fraven, which is the first biosimilar drug, developed and manufactured from cell to final product in Turkey. Additionally, Arven is the first Turkish company to design and develop a patented Dry Powder Inhaler (DPI) device under Arvohaler trademark and globally introduced Cyplos (salmeterol/fluticasone) product inhaled with Arvohaler device. Some of the ministry of health foundations have visitations to the company for the vaccine manufacturing potential during Covid-19 pandemic period.potential during Covid-19 pandemic period.
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Arven_K%C4%B1rklareli_Facility.jpg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageID
|
66165645
|
| http://dbpedia.org/ontology/wikiPageLength
|
10156
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1120838720
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/File:Arven_RD_center.jpg +
, http://dbpedia.org/resource/European_Medicines_Agency +
, http://dbpedia.org/resource/European_Patent_Office +
, http://dbpedia.org/resource/Cell_culture +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_Turkey +
, http://dbpedia.org/resource/Patent +
, http://dbpedia.org/resource/Fluticasone/salmeterol +
, http://dbpedia.org/resource/Inoculation +
, http://dbpedia.org/resource/Food_and_Drug_Administration +
, http://dbpedia.org/resource/Good_manufacturing_practice +
, http://dbpedia.org/resource/Filgrastim +
, http://dbpedia.org/resource/Tiotropium_bromide +
, http://dbpedia.org/resource/Inhaler +
, http://dbpedia.org/resource/Japan_Patent_Office +
, http://dbpedia.org/resource/United_States_Patent_and_Trademark_Office +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Upstream_and_downstream_%28DNA%29 +
, http://dbpedia.org/resource/Comparability +
, http://dbpedia.org/resource/Downstream_processing +
, http://dbpedia.org/resource/World_Health_Organization +
, http://dbpedia.org/resource/Category:Biotechnology +
, http://dbpedia.org/resource/Istanbul +
, http://dbpedia.org/resource/Monoclonal_antibody +
, http://dbpedia.org/resource/Fermentation +
, http://dbpedia.org/resource/Dry-powder_inhaler +
, http://dbpedia.org/resource/File:Arven_K%C4%B1rklareli_Facility.jpg +
, http://dbpedia.org/resource/Category:Pharmaceutical_industry +
, http://dbpedia.org/resource/Analysis +
, http://dbpedia.org/resource/Biosimilar +
, http://dbpedia.org/resource/COVID-19_pandemic +
, http://dbpedia.org/resource/Chromatography +
, http://dbpedia.org/resource/K%C4%B1rklareli +
, http://dbpedia.org/resource/Ministry_of_Health_%28Turkey%29 +
, http://dbpedia.org/resource/Pharmaceutical +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Convert +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_Turkey +
, http://dbpedia.org/resource/Category:Pharmaceutical_industry +
, http://dbpedia.org/resource/Category:Biotechnology +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Arven_Pharmaceuticals?oldid=1120838720&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Arven_K%C4%B1rklareli_Facility.jpg +
, http://commons.wikimedia.org/wiki/Special:FilePath/Arven_RD_center.jpg +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Arven_Pharmaceuticals +
|
| owl:sameAs |
http://dbpedia.org/resource/Arven_Pharmaceuticals +
, http://www.wikidata.org/entity/Q104835323 +
, https://global.dbpedia.org/id/FU77j +
|
| rdfs:comment |
Arven Pharmaceuticals is a Turkish pharmac … Arven Pharmaceuticals is a Turkish pharmaceutical corporation headquartered in Istanbul established as a subsidiary of Toksöz Group in 2013. Arven’s primary focus is development and production of high-technology inhaler and biotechnology products. The company is specialized on difficult to make products. Arven is the first Turkish company developing biosimilars for global markets, including the US and EU. Some of the ministry of health foundations have visitations to the company for the vaccine manufacturing potential during Covid-19 pandemic period.potential during Covid-19 pandemic period.
|
| rdfs:label |
Arven Pharmaceuticals
|
